HAEMORRHAGIC THYROID CYST

This adverse event was reported 12 times

These drugs are most commonly taken by patients reporting HAEMORRHAGIC THYROID CYST:

# Drug Count
0 CLOPIDOGREL BISULFATE 4
1 HYDROXYUREA 4
2 CLOPIDOGREL 3
3 TENECTEPLASE 2
4 (SALINE) 1
5 ALEMTUZUMAB 1
6 APIXABAN 1
7 ASPIRIN 1
8 ASPIRIN 325 MG 1
9 ASPIRIN 81 MG 1
See all common drugs associated with HAEMORRHAGIC THYROID CYST

HAEMORRHAGIC THYROID CYST is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TENECTEPLASE 2 0.0013
1 SALINE NASAL SPRAY 1 0.0002
2 HYDROXYUREA 4 0.0002
3 PRASUGREL HYDROCHLORIDE 1 0.0001
4 ALEMTUZUMAB 1 0.0001
5 CLOPIDOGREL BISULFATE 4 0.0000
6 MIDAZOLAM HYDROCHLORIDE 1 0.0000
7 HYDROXYZINE 1 0.0000
8 CLOPIDOGREL 3 0.0000
9 APIXABAN 1 0.0000
See all drugs enriched for association with HAEMORRHAGIC THYROID CYST

HAEMORRHAGIC THYROID CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
1 P2Y12 Platelet Inhibitor [EPC] 3 0.0000
2 Interferon beta [EPC] 1 0.0000
3 Factor Xa Inhibitor [EPC] 1 0.0000
4 GLP-1 Receptor Agonist [EPC] 1 0.0000
5 Platelet Aggregation Inhibitor [EPC] 1 0.0000
6 Benzodiazepine [EPC] 1 0.0000
7 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with HAEMORRHAGIC THYROID CYST